Delivery Order SPE2DE24D0013-SPE2D626F04F5
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $5,775.00 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. The delivery order, designated XPRS-COV2-10, is expected to be completed by November 20, 2025, and carries no set-aside designation. This award represents a task order issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $6,800 firm fixed-price delivery order (Contract No. 4570311585, XPRS4PLEX-10) by the Defense Logistics Agency's Medical Supply Chain on December 16, 2025, with an ultimate completion date of December 23, 2025. This delivery order, which carries no set-aside designation, is issued under a larger Indefinite Delivery Contract (IDC) established with the Department of Veterans Affairs VISN 17, valued at $6.7 million through December...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,482.28 by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,647.80 by the Defense Logistics Agency Medical Supply Chain on December 18, 2025, with an ultimate completion date of January 5, 2026. This firm fixed-price delivery order, designated XPRSARS-COV2-10, procures molecular diagnostic reagents and test kits for the GeneXpert diagnostic platform, specifically XPRS-COV2-10 cartridges used for detecting respiratory pathogens including COVID-19. The...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,270.50 by the Defense Logistics Agency's Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 19, 2025. The delivery order, designated XPRSARS-COV2-10, is issued under a firm fixed-price contract structure with no set-aside designation. This award represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $1,925 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on October 21, 2025, with an ultimate completion date of October 28, 2025. The contract, designated XPRS-COV2-10, represents a delivery order for diagnostic reagents and test kits—specifically XPRS-COV2-10 cartridges for respiratory pathogen detection on the GeneXpert diagnostic platform....
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $2,040 delivery order (Contract No. 4570200483, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 5, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is for molecular diagnostic testing supplies and reagents for the GeneXpert diagnostic platform. The award represents a continuation of Cepheid's established...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $4,620 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency component) on September 5, 2025, with an ultimate completion date of September 12, 2025. The contract, designated XPRS-COV2-10, carries no set-aside designation and represents work to be performed in Sunnyvale, California. This delivery order likely draws from one of Cepheid's two significant Indefinite...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F04F5Delivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $28,875 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 17, 2025. This delivery order, designated XPRS-COV2-10, was issued with no set-aside designation and represents procurement of diagnostic testing supplies under Cepheid's existing Indefinite Delivery Contract framework with the Department of Veterans Affairs. The contract specifies performance at Cepheid's Sunnyvale facility and focuses on the delivery of respiratory pathogen detection cartridges and associated molecular diagnostic reagents designed for use with the company's GeneXpert diagnostic platform. As a primary federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has established extensive relationships across multiple federal healthcare agencies including the VA, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's core competencies encompass rapid molecular diagnostic testing for COVID-19, influenza, and other infectious diseases through its GeneXpert platform. This delivery order represents routine procurement activity consistent with Cepheid's substantial federal contract portfolio, which includes multiple IDCs valued in the tens of millions of dollars and numerous smaller delivery orders supporting federal healthcare laboratory operations and infectious disease testing requirements across distributed networks of medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.9k | 12/9/25 |